Please login to the form below

Not currently logged in


This page shows the latest Erelzi news and features for those working in and with pharma, biotech and healthcare.

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

The Novartis subsidiary was looking to the case in the District Court of New Jersey to clear some of the barriers to the commercial launch of the biosimilar, called Erelzi ... We will appeal this decision, and look forward to presenting our case to the

Latest news

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...